Advertisements

Seasonique

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Seasonique

Quick Facts

Property Description
Active Ingredients Levonorgestrel, Ethinyl Estradiol
Form Oral Tablets
Pharmacological Class Hormonal Contraceptive (Combined Oral Contraceptive)
Common Use Prevention of Pregnancy
Origin Synthetic Hormonal Compound

What Type of Contraceptive is Seasonique?

Seasonique is a synthetic, prescription-only (Rx) Combined Oral Contraceptive (COC) intended exclusively for the prevention of pregnancy in women of reproductive age. This medication belongs to the broader pharmacological class of Hormonal Contraceptives, specifically those that combine an estrogen and a progestin. The product is clinically recognized as an effective form of primary birth control, supported by established regulatory standards.


Composition and the Extended-Cycle Formulation

The medication's composition includes two active ingredients: Levonorgestrel (a synthetic progestin) and Ethinyl Estradiol (a synthetic estrogen). Seasonique is primarily characterized by its extended-cycle or 91-day regimen, a distinguishing feature that sets it apart from traditional monthly contraceptive packs. This specific schedule involves 84 consecutive days of active combination hormones, followed by a 7-day period of tablets containing only a low dose of Ethinyl Estradiol. This structure deliberately lengthens the active hormonal phase.


How Seasonique Prevents Pregnancy (High-Level Purpose)

The highly effective nature of Seasonique is due to its dual physiological action focused on pregnancy prevention. The core mechanism involves the inhibition of ovulation, preventing the ovaries from releasing an egg. Combined hormonal contraceptives achieve their effect primarily through the central suppression of gonadotropins. Furthermore, the hormones also cause physical changes, such as thickening the cervical mucus and altering the uterine lining, ensuring a multi-pronged contraceptive effect. The unique benefit of the 91-day regimen is the scheduled reduction of withdrawal bleeding episodes to approximately four times per year, offering a simplified cycle structure for patients.

Regulatory References

  1. National Institutes of Health (NIH) confirms
Advertisements

What side effects are possible with Seasonique?

Possible Side Effects and Safety Information

The official safety information for Seasonique emphasizes risks associated with serious vascular events, while also documenting common and less severe adverse reactions.

Serious Risks and Contraindications

Official labeling includes a Boxed Warning regarding the increased risk of serious cardiovascular events from combination oral contraceptives, particularly in women who smoke and are over 35 years of age. For this reason, use is contraindicated in this specific population. Life-threatening events that have been associated with this class of medicine include arterial and venous thromboembolism, such as Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Myocardial Infarction (heart attack), and Stroke.

Other medically significant risks mentioned in regulatory documents include Liver Tumors (benign or malignant), Gallbladder Disease, and the potential for new onset or worsening Hypertension (high blood pressure). Discontinuation is generally required if a thrombotic event or jaundice occurs.

Common Adverse Reactions

The most common adverse reactions (ge 5%) reported in clinical trials are irregular and/or heavy uterine bleeding, weight gain, and acne. Other adverse reactions commonly reported by combined oral contraceptive users include headache, nausea, breast tenderness, and mood changes. Due to the extended-cycle regimen, this medicine provides greater cumulative annual hormonal exposure compared to conventional 28-day oral contraceptives.

Advertisements

Overdose and Emergency Response

Overdose and When to Seek Help

This section details the official overdose profile for Seasonique based strictly on government regulatory documents.

Overdose Scope Official Regulatory Statement
Documented Manifestations Nausea, Vomiting, and Withdrawal bleeding (vaginal bleeding) are the primary clinical manifestations listed following overingestion.
Severity Classification Overdose is generally not likely to be life-threatening. Regulatory information indicates no serious problems have been reported, even in cases of accidental ingestion by children.
Emergency Action Required Patients must seek emergency medical attention and contact the Poison Help hotline immediately following any suspected overingestion.
Antidote and Treatment Treatment is exclusively symptomatic and supportive. The prescribing information confirms that no specific antidote is known for an overdose involving these active ingredients.

The official regulatory profile for Seasonique overdose is defined by its low acute toxicity. While the risk of severe outcome is low, immediate professional guidance is a non-negotiable requirement. The mandated procedure is to seek emergency medical attention to ensure appropriate symptomatic management and monitoring of vital signs are carried out. This approach underscores the need for expert consultation following any suspected overingestion, as dictated by regulatory standards.

Advertisements

Therapeutic Uses of Seasonique

What Seasonique Treats: Main Uses and Benefits

Seasonique is an extended-cycle hormonal contraceptive commonly used to help with pregnancy prevention for women of reproductive age. It is indicated for use by women to prevent pregnancy. The medication is also generally applied in addressing symptoms related to physical discomfort and tension in the menstrual cycle.


Key Therapeutic Applications

The medication is commonly used to help with the management of conditions characterized by pronounced symptoms such as Dysmenorrhea (severe cramping and pain), Menorrhagia (excessively heavy bleeding), and symptom clusters associated with Premenstrual Syndrome (PMS) and PMDD. A distinguishing feature of the 91-day regimen is the intentional reduction of scheduled withdrawal bleeding episodes to approximately four times per year. This practical benefit is particularly relevant for patients who seek assistance with managing the frequency of menstruation.

This regimen may assist with maintaining functional stability and helps improve day-to-day comfort by lessening the impact of recurrent monthly symptoms.

By addressing these issues, the medication provides supportive relief when symptoms interfere with routine activities, assisting with maintaining functional stability.


Quick Fact: Supportive Symptom Management

Symptom Category Therapeutic Benefit
Menstrual Pain (Dysmenorrhea) Plays a role in managing the intensity of cramping.
Heavy Bleeding (Menorrhagia) May assist with managing the volume and duration of flow.
PMDD/PMS Symptoms Contributes to managing emotional and physical swings.
Advertisements

Eligibility and Restrictions for Use

Seasonique is an extended-cycle combination oral contraceptive that is not suitable for all women. Official regulatory documents strictly outline several populations for whom use is prohibited or requires special consideration.

Populations for Whom Use is Contraindicated

Use is contraindicated if a woman is pregnant or has a high risk of blood clotting (thrombotic) disorders. This includes current or history of deep vein thrombosis, pulmonary embolism, stroke, heart disease, or inherited hypercoagulopathies. Women over age 35 who smoke must not use this medicine due to a significantly increased risk of serious cardiovascular events.

Other absolute contraindications include known or suspected breast cancer or other estrogen- or progestin-sensitive cancers, undiagnosed abnormal uterine bleeding, and liver disease (e.g., liver tumors, acute viral hepatitis, or decompensated cirrhosis).

Other Eligibility Restrictions

Seasonique is not recommended for nursing mothers, as it may decrease milk production. The drug must also be discontinued prior to and after major surgery or during prolonged immobilization due to increased thromboembolic risk. Women with diabetes or hypertension require special caution, and use is contraindicated if these conditions are uncontrolled or complicated.

Advertisements

What should I know about interactions with other medicines?

The official regulatory profile for Seasonique (Levonorgestrel/Ethinyl Estradiol) defines specific interaction patterns that can alter the systemic levels of the active hormones or affect co-administered drugs. These patterns are based on pharmacokinetic consequences documented by government health authorities.

Regulatory Prohibitions and Restrictions

Co-administration is formally contraindicated with certain hepatitis C treatments, specifically combinations containing Ombitasvir, Paritaprevir, and Ritonavir, sometimes including Dasabuvir. This prohibition is due to the documented risk of significant liver enzyme elevations. Furthermore, use is contraindicated in women over 35 years of age who smoke, as this combination significantly increases the risk of serious cardiovascular events.

Enzyme and Absorption Interactions

The concentration of Seasonique's hormones may be altered by substances that modify metabolic enzyme activity. Enzyme-inducing medicines (e.g., Carbamazepine, Phenytoin, or the herbal product St. John’s wort) are documented to decrease the systemic exposure of the hormones. Conversely, metabolic enzyme inhibitors (e.g., Itraconazole) and certain statins like Atorvastatin are shown to increase the systemic exposure of Ethinyl Estradiol.

A specific timing requirement exists for the bile acid sequestrant Colesevelam, which must be administered 4 or more hours apart from Seasonique to prevent a documented reduction in Ethinyl Estradiol absorption. Additionally, the hormonal components of Seasonique can induce the glucuronidation of other medicines, such as the anticonvulsant Lamotrigine, thereby reducing its plasma concentration.

Advertisements

Mechanism of Action

The mechanism of Seasonique involves a coordinated dual action achieved through the receptor agonism of its two synthetic hormones. This system establishes a multi-pronged physiological blockade.

Central Endocrine Suppression (Anovulation)

This domain focuses on the hormones acting as agonists at the Estrogen ( ER) and Progesterone ( PR) receptors in the brain's endocrine centers. This receptor engagement triggers a negative feedback signal that suppresses the release of Gonadotropins ( LH and FSH), effectively preventing the ovaries from maturing and releasing an egg (anovulation). The central action establishes the primary physiological mechanism.

Peripheral Tissue Modulation and Barrier Formation

The second domain involves direct, local effects on the reproductive tissues, acting as a secondary physiological blockade. The progestin component modulates the cervical glands, causing the mucus to become extremely thick and dense, thereby impeding the ascent of sperm. Concurrently, the hormones modify the endometrial lining, inducing changes that render the uterine environment unreceptive to implantation.

Advertisements

Dosage and Administration Information

Seasonique is an extended-cycle combined oral contraceptive (COC) taken continuously for 91 days. To ensure maximum effectiveness, one tablet must be taken by mouth at the same time every day and at intervals not exceeding 24 hours, exactly as directed on the blister pack.

Dosing Schedule (91-Day Cycle)

The 91-day course consists of two different types of tablets taken sequentially:

  • Active Tablets (84 Days): Take one light blue-green tablet (containing levonorgestrel/ethinyl estradiol) daily for 84 consecutive days. This is the main phase of the contraceptive cycle.
  • Estrogen-Only Tablets (7 Days): Follow the active tablets with one yellow tablet (containing only ethinyl estradiol) daily for 7 consecutive days. A scheduled withdrawal bleed is expected to occur during this week.

Starting Seasonique

The recommended initiation is on the first Sunday after the onset of menstruation. If menstruation begins on a Sunday, the first light blue-green tablet should be taken that same day. For women who start any later than the first day of their menstrual period, a non-hormonal back-up method of contraception (such as condoms) should be used until the light blue-green tablets have been taken daily for 7 consecutive days.

Advertisements

Recent Clinical Evidence

Seasonique: Recent Clinical Evidence

Clinical research has focused primarily on the use of Seasonique for pregnancy prevention and its effect on the menstrual cycle. This product is an extended-cycle oral contraceptive, designed to reduce the total number of menstrual cycles experienced annually.


Efficacy and Cycle Control Studies

Studies investigating the effectiveness of this regimen for preventing pregnancy reported outcomes consistent with other low-dose combination oral contraceptives. The treatment involves a regimen of 84 active pills followed by 7 low-dose estrogen pills, resulting in four scheduled bleeding periods per year, as opposed to the typical 13 associated with conventional 28-day regimens.

  • Reduction in Bleeding Episodes: Key trials evaluated the change in the number of scheduled bleeding periods. Participants experienced a significant reduction, achieving four scheduled episodes annually.
  • Bleeding Patterns: Researchers monitored unscheduled bleeding (spotting or breakthrough bleeding). Findings indicated that unscheduled bleeding or spotting was commonly reported, especially during the first few cycles of use, before decreasing with continued use.

Tolerability and Safety Profile

In clinical trials, the overall safety profile was reported to be similar to that of conventional 28-day oral contraceptives. The most frequently reported adverse events included unscheduled bleeding, headaches, and nausea. Safety research protocols focused on monitoring for cardiovascular events, including venous thromboembolism (VTE), which is a known risk associated with all combination hormonal contraceptives.

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Seasonique (FAQ)

Q: What is the main purpose of Seasonique, besides preventing pregnancy?

According to the official regulatory profile, Seasonique is indicated solely for the prevention of pregnancy in women of reproductive potential. The official documentation does not list additional approved indications for this specific medicine.


Q: Does Seasonique have a generic version available, and is it considered the same?

The FDA has approved generic versions of Seasonique. Regulatory standards require that generic drugs meet the same quality, strength, purity, and efficacy standards as the brand name product.


Q: How long does it typically take for the body to adjust to the Seasonique dosing schedule?

Official clinical trial data indicates that unscheduled bleeding or spotting is a common experience, especially during the first few cycles of use. Adjustment is generally observed in clinical studies, and this unscheduled bleeding is reported to decrease with continued use of the medicine.


Q: Are there any long-term effects of using an extended-cycle pill like Seasonique for many years?

Long-term use of this class of medicine is associated with known risks, including an increased risk of serious cardiovascular events, liver tumors, and gallbladder disease. These potential long-term effects are addressed in the official safety warnings for all combined oral contraceptives.


Q: Can Seasonique be used by women who have a history of migraines with aura?

According to the official prescribing information, Seasonique is formally contraindicated for women with a history of migraines with aura. This restriction is due to an increased risk of stroke associated with this specific combination of medicine and medical condition.


Q: What is the risk of blood clots (thrombosis) while taking Seasonique, and what are the signs to look for?

The official safety information states that the risk of blood clots (thrombosis) is increased for all women using combination hormonal contraceptives. Regulatory documents specify that a healthcare provider should be contacted immediately if symptoms are experienced, such as persistent leg pain, severe chest pain, or sudden shortness of breath, as these may indicate a thrombotic event.


Q: What medications or supplements should be avoided while taking Seasonique?

The official product label formally contraindicates co-administration with certain Hepatitis C treatment combinations. Additionally, the effectiveness of the contraceptive may be reduced by specific medicines and herbal products, such as St. John’s wort, that are known to interfere with the hormones' metabolism.


Q: Does Seasonique affect mood, and is there a reported link to mood swings or depression?

Mood changes are listed in the official adverse reaction profile as a possible effect. Regulatory documents mention that mental or mood changes, such as new or worsening depression, should be discussed with a healthcare provider for evaluation.


Q: What should be done if I experience vomiting or severe diarrhea shortly after taking a Seasonique pill?

Regulatory documents state that severe vomiting or diarrhea may reduce the effectiveness of the pill by preventing complete absorption of the hormones. Regulatory documents describe the need for a non-hormonal back-up method of contraception until the issue resolves.


Q: Can Seasonique be taken continuously to skip all periods, even the scheduled ones?

The FDA-approved dosing regimen is the 91-day cycle, which consists of 84 consecutive active pills followed by 7 low-dose estrogen pills. This specific schedule is designed to result in four scheduled withdrawal bleeding periods per year.


Q: Is hair loss or hair growth a documented side effect of Seasonique?

Postmarketing reports have documented effects such as alopecia (hair loss) and hirsutism (increased hair growth) as possible, though not commonly reported, adverse reactions of the medicine.


Q: Can taking Seasonique make contact lenses feel uncomfortable?

Official patient information mentions that some women may experience problems tolerating contact lenses or increased discomfort while wearing them.


Q: Does Seasonique have any known effects on cholesterol or triglyceride levels?

Official safety warnings state that the medicine may cause adverse carbohydrate and lipid metabolic effects. Use is associated with elevations in triglyceride levels, particularly in women with pre-existing hypertriglyceridemia.


Q: Is Seasonique still effective if I take the pill a few hours late?

To achieve maximum contraceptive effectiveness, the official label states the tablet is intended to be taken at the same time every day and at intervals not exceeding 24 hours. Exceeding the 24-hour interval increases the risk of reduced effectiveness.


Q: How does Seasonique's hormone exposure compare to a traditional monthly pill over the course of a year?

Due to the extended 91-day regimen, official safety information indicates that this medicine provides greater cumulative annual hormonal exposure when compared to conventional 28-day oral contraceptives.


Q: Does Seasonique affect the results of any routine blood tests?

According to the official product information, the hormonal components are known to affect the results of certain laboratory tests. These include tests of coagulation, lipids, and thyroid-binding globulin.


Q: What is the difference between Seasonique and LoSeasonique?

Both products are extended-cycle combination oral contraceptives. The difference is in the lower dose of the estrogen component contained within the active pills of LoSeasonique compared to Seasonique.


Q: Is there any research evidence comparing Seasonique to other types of long-cycle contraceptives?

Official clinical trials focused primarily on comparing the regimen’s efficacy and cycle control to conventional 28-day combination oral contraceptives. Research evidence specific to comparison against other long-cycle contraceptives is not emphasized in the regulatory summary.


Q: Does Seasonique protect against sexually transmitted infections (STIs)?

Official patient information clearly states that Seasonique does not protect against HIV/AIDS or other sexually transmitted diseases.


Q: What is the recommended timeframe to start Seasonique after giving birth or a second-trimester abortion?

For women who are not breastfeeding, the recommended start date is generally no earlier than 4 weeks after delivery. Following a first-trimester abortion or miscarriage, the medicine can be started on the Sunday after the event, while a second-trimester abortion requires waiting 4 weeks.


Q: Can Seasonique increase the risk of certain cancers, such as breast or cervical cancer?

Official documents cite an association with an increased risk of benign hepatic adenomas and hepatocellular carcinomas. Additionally, research shows that long-term use is associated with a small increase in cervical cancer risk. Breast cancer is listed as a condition that prevents the use of the medicine.


Q: Are there specific patient groups for whom the effectiveness of Seasonique may be reduced?

Regulatory documents for this class of medicine have noted that reduced contraceptive effectiveness may occur in women with a Body Mass Index (BMI) of 30 kg/m² or greater.


Q: What is the official definition of 'breakthrough bleeding' when referring to extended-cycle birth control?

In clinical terms, breakthrough bleeding is officially categorized as unscheduled bleeding or spotting that occurs outside of the expected 7-day scheduled withdrawal period in the 91-day cycle.


Q: Does Seasonique affect libido or sex drive?

The official adverse event profile includes decreased interest in sexual intercourse or decreased sex drive as a possible, though not commonly reported, adverse reaction.


Q: What are the signs of an allergic reaction to Seasonique?

Official patient information describes signs of a serious allergic reaction, such as hives, difficulty breathing, or swelling of the face, lips, or throat, as symptoms that necessitate immediate medical evaluation.


Q: Is fluid retention or bloating a common side effect of Seasonique?

The official adverse event profile lists fluid retention, or edema, and bloating as possible side effects of the medicine.


Q: How does the extended cycle impact a woman's body compared to a monthly cycle?

The primary impact of the extended cycle, as documented in clinical studies, is the scheduled reduction of withdrawal bleeding episodes from the typical 13 episodes per year down to approximately four per year.


Q: Does Seasonique affect the progression of fibroids?

Product monographs for this class of medicine have noted that the presence of uterine fibroids may be aggravated by use of hormonal contraceptives.


Q: What is the difference between the pink and the light blue-green Seasonique pills?

The official blister pack contains two types of tablets: light blue-green tablets, which are the active combination hormones, and yellow tablets, which contain only a low dose of estrogen. There are no pink tablets in the FDA-approved Seasonique regimen.


Q: Can a high-level cholesterol disorder prevent the use of Seasonique?

Use is contraindicated in patients with known abnormalities of the blood clotting system. Caution is required in patients with hyperlipidemia, which includes high cholesterol and triglyceride levels.


Q: Is there a link between Seasonique use and changes in vision?

Regulatory documents describe that blurred vision, difficulty in reading, or any other change in vision should be medically evaluated.


Q: What are the symptoms of a Seasonique overdose?

Symptoms of a Seasonique overdose may include feeling sick or vomiting, dizziness, or withdrawal bleeding (menstrual bleeding).


Q: What happens if I miss a yellow (estrogen-only) tablet?

If a yellow (estrogen-only) tablet is missed, the official instructions recommend discarding the tablet and continuing with the scheduled pills until the pack is finished. A back-up method of contraception is not considered necessary for missed estrogen-only pills.


Q: What happens if I miss a pink (active) Seasonique tablet during the first week of a new cycle?

Official instructions for a missed active tablet are specific and depend on how many pills were missed and when. Missing one active pill requires taking it as soon as remembered. Missing two or more active pills in a row requires specific guidance to maintain effectiveness, which often includes the temporary use of a non-hormonal back-up method for 7 days.


Q: What is the risk of having a period or spotting if a tablet is missed?

Missing active pills can disrupt the regular hormonal pattern and may cause unscheduled bleeding or spotting, even when the missed pills are taken later.


Q: Can Seasonique cause headaches, and are these different from migraines?

Headache is listed as a commonly reported adverse reaction. Official labeling specifically states that use is contraindicated for women who experience migraines with aura, as this combination increases the risk of stroke.


Q: What are the signs of a serious liver problem that require stopping Seasonique immediately?

Regulatory documents indicate that the drug's discontinuation is generally necessary if jaundice (yellowing of the skin or eyes) occurs. Other serious signs reported, such as severe upper stomach pain, loss of appetite, dark urine, and clay-colored stools, require medical evaluation.

Advertisements

How should Seasonique be stored and disposed of?

Storage and Disposal Requirements for Seasonique

The storage of Seasonique tablets is strictly defined by regulatory labeling to maintain product stability and quality.

Mandatory Storage Conditions

Seasonique must be stored at Controlled Room Temperature, which is specifically defined as 20°C to 25°C (68°F to 77°F). The tablets should be kept in their original container (Extended-Cycle Tablet Dispenser) and protected from adverse environmental conditions, including excessive heat, light, and moisture.

As a crucial safety measure for all medications, Seasonique must be stored in a location that is out of the sight and reach of children.

Disposal of Unused Product

Unused or expired Seasonique tablets must be disposed of safely according to local regulations and guidelines for pharmaceutical waste. The product should not be discarded in household trash or poured down a drain or into wastewater.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Seasonique found in:

A-Z Index: